Mechanisms for inhibition of P2 receptors signaling in neural cells
Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides rel...
Saved in:
Published in | Molecular neurobiology Vol. 31; no. 1-3; pp. 65 - 79 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Springer Nature B.V
01.01.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y2 nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y2 receptor-induced ERK1/2 and p38 phosphorylation and P2Y2 receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y2 receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y2 receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders. |
---|---|
AbstractList | Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y2 nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y2 receptor-induced ERK1/2 and p38 phosphorylation and P2Y2 receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y2 receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y2 receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders. Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y^sub 2^ nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y^sub 2^ receptor-induced ERK1/2 and p38 phosphorylation and P2Y^sub 2^ receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y^sub 2^ receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y^sub 2^ receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders.[PUBLICATION ABSTRACT] Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that cause the activation of astrocytes, little is known about the molecular mechanisms underlying the regulation of this process. Nucleotides released into the extracellular space from injured or dying neural cells can activate astrocytes via P2 nucleotide receptors. After a brief historical review and update of novel P2 receptor antagonists, this article focuses on recent advancements toward understanding molecular mechanisms that regulate G protein-coupled P2Y receptor signaling. Among P2Y receptor subtypes, the heptahelical P2Y sub(2) nucleotide receptor interacts with vitronectin receptors via an RGD sequence in the first extracellular loop, and this interaction is required for effective signal transduction to activate mitogen-activated protein kinases ERK1/2, to mobilize intracellular calcium stores via activation of phospholipase C, protein kinase C isoforms, and to activate focal adhesion kinase and other signaling events. Ligation of vitronectin receptors with specific antibodies caused an inhibition of P2Y sub(2) receptor-induced ERK1/2 and p38 phosphorylation and P2Y sub(2) receptor-induced cytoskeleton rearrangement and DNA synthesis. Structure-function studies have identified agonist-induced phosphorylation of the C-terminus of the P2Y sub(2) receptor, an important mechanism for receptor desensitization. Understanding selective mechanisms for regulating P2Y sub(2) receptor signaling could provide novel targets for therapeutic strategies in the management of brain injury, synaptogenesis, and neurological disorders. |
Author | Seye, Cheikh I Erb, Laurie Velázquez, Betty González, Fernando A Sun, Grace Y Hernández-Pérez, Melvin Chorna, Nataliya E Weisman, Gary A |
Author_xml | – sequence: 1 givenname: Fernando A surname: González fullname: González, Fernando A email: fgonzal@u.pracd.upr.clu.edu organization: Department of Chemistry, University of Puerto Rico, Río Piedras Campus, Puerto Rico. fgonzal@u.pracd.upr.clu.edu – sequence: 2 givenname: Gary A surname: Weisman fullname: Weisman, Gary A – sequence: 3 givenname: Laurie surname: Erb fullname: Erb, Laurie – sequence: 4 givenname: Cheikh I surname: Seye fullname: Seye, Cheikh I – sequence: 5 givenname: Grace Y surname: Sun fullname: Sun, Grace Y – sequence: 6 givenname: Betty surname: Velázquez fullname: Velázquez, Betty – sequence: 7 givenname: Melvin surname: Hernández-Pérez fullname: Hernández-Pérez, Melvin – sequence: 8 givenname: Nataliya E surname: Chorna fullname: Chorna, Nataliya E |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15953812$$D View this record in MEDLINE/PubMed |
BookMark | eNp90T1PwzAQBmALgSgFRlYUMcAUOPsSx-6GKr6ktjDAbDmpTY1Su9jNwL8nVSuBGJjuhkev7mNI9n3whpAzCtcURXkznY2QjmiOI-DlHjkCITGveCH2f_UDMkzpA4AxCtUhGdBSligoOyLjqWkW2ru0TJkNMXN-4Wq3dsFnwWYvLIumMat1iClL7t3r1vn3HmXedFG3WWPaNp2QA6vbZE539Zi83d-9jh_zyfPD0_h2kjdYleucykIDIhS6ZihqWVhr5rYRhhYSGC9KwTloYZAKhmCFrJrKIlKNALKWHI_J1TZ3FcNnZ9JaLV3aTKC9CV1SggNWrCygl5f_Sl7JPhg2kRd_4EfoYr9mUowWAigvWY_yLWpiSCkaq1bRLXX8UhTU5glqOlNIFVWo-if0_nwX2tVLM__Ru6vjN4NOgQM |
CitedBy_id | crossref_primary_10_1096_fj_201701064RR crossref_primary_10_1104_pp_110_162503 crossref_primary_10_1080_02772240701382131 crossref_primary_10_1021_bi051517w crossref_primary_10_1523_JNEUROSCI_5338_05_2006 crossref_primary_10_1007_s00702_008_0067_y crossref_primary_10_1097_01_fpc_0000189798_11468_6a crossref_primary_10_4049_jimmunol_178_2_720 crossref_primary_10_1177_039463200702000210 crossref_primary_10_1016_j_resp_2008_04_020 crossref_primary_10_1007_s12035_012_8263_z crossref_primary_10_1007_s00424_006_0071_8 crossref_primary_10_1007_s11302_006_9035_x crossref_primary_10_1152_ajpcell_00100_2009 crossref_primary_10_1002_jcp_20946 crossref_primary_10_1016_j_mehy_2006_01_010 crossref_primary_10_1111_dgd_12156 crossref_primary_10_4049_jimmunol_179_9_6016 crossref_primary_10_1177_039463200601900207 |
ContentType | Journal Article |
Copyright | Humana Press Inc. 2005 |
Copyright_xml | – notice: Humana Press Inc. 2005 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QR 7TK 7X7 7XB 88A 88E 88G 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M2P M7P P64 PQEST PQQKQ PQUKI PRINS PSYQQ Q9U 7X8 |
DOI | 10.1385/MN:31:1-3:065 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Chemoreception Abstracts Neurosciences Abstracts Health Medical collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Psychology Database (ProQuest) Science Journals (ProQuest Database) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest One Psychology ProQuest Central Student Technology Research Database ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection Chemoreception Abstracts ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest One Psychology Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 0893-7648 1559-1182 |
EndPage | 79 |
ExternalDocumentID | 1940183381 10_1385_MN_31_1_3_065 15953812 |
Genre | Research Support, U.S. Gov't, P.H.S Review Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCRR NIH HHS grantid: P20 RR-15565 – fundername: NIGMS NIH HHS grantid: S06 GM-08102 |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 123 1N0 2.D 203 28- 29M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 3V. 4.4 406 408 40D 40E 53G 5VS 67N 6NX 78A 7X7 88A 88E 88I 8AO 8CJ 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAEOY AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAQLM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIVO ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACGOD ACHSB ACHXU ACIPQ ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACZOJ ADBBV ADHHG ADHIR ADINQ ADKNI ADKPE ADOJD ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFGCZ AFKRA AFLOW AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AIAKS AIGIU AIIXL AILAN AITGF AIZAD AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI CAG CCPQU CGR COF CS3 CSCUP CUY CVF D1J DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS ECM EIF EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 H13 HCIFZ HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ ITM IWAJR IXC I~X I~Z J-C J0Z JBSCW JZLTJ KDC KOV LK8 LLZTM M0L M1P M2M M2P M4Y M7P MA- N2Q N9A NDZJH NF0 NPM NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PQQKQ PROAC PSQYO PSYQQ PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TEORI TSG TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 XJT YLTOR Z7U Z7W Z82 Z83 Z87 Z8O Z8V Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAYXX ADOAH CITATION 7QR 7TK 7XB 8FD 8FK FR3 K9. P64 PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c375t-194a03304ab238b94ffedfc8e149026458660a8e318230f897c7f331a3009b963 |
IEDL.DBID | BENPR |
ISSN | 0893-7648 |
IngestDate | Fri Oct 25 02:33:33 EDT 2024 Thu Oct 24 23:52:08 EDT 2024 Thu Oct 10 16:43:26 EDT 2024 Thu Sep 12 17:35:14 EDT 2024 Tue Oct 15 23:30:41 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1-3 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c375t-194a03304ab238b94ffedfc8e149026458660a8e318230f897c7f331a3009b963 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 ObjectType-Feature-1 |
PMID | 15953812 |
PQID | 214801652 |
PQPubID | 55365 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_860372540 proquest_miscellaneous_67933106 proquest_journals_214801652 crossref_primary_10_1385_MN_31_1_3_065 pubmed_primary_15953812 |
PublicationCentury | 2000 |
PublicationDate | 2005-01-01 |
PublicationDateYYYYMMDD | 2005-01-01 |
PublicationDate_xml | – month: 01 year: 2005 text: 2005-01-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Totowa |
PublicationTitle | Molecular neurobiology |
PublicationTitleAlternate | Mol Neurobiol |
PublicationYear | 2005 |
Publisher | Springer Nature B.V |
Publisher_xml | – name: Springer Nature B.V |
References | 9257926 - Br J Pharmacol. 1997 Aug;121(7):1445-53 12586354 - FEBS Lett. 2003 Feb 11;536(1-3):145-50 11734618 - Pharmacol Rev. 2001 Dec;53(4):553-68 11099776 - Neurochem Int. 2001 Mar;38(3):189-97 2818584 - Biochem Biophys Res Commun. 1989 Oct 31;164(2):706-13 14514872 - J Physiol. 2003 Dec 15;553(Pt 3):683-94 4270904 - Biochim Biophys Acta. 1973 Oct 5;320(3):635-47 10821429 - Mol Cell Biochem. 2000 Feb;205(1-2):115-23 8895885 - Neuroscience. 1996 Oct;74(4):1187-96 11521173 - Naunyn Schmiedebergs Arch Pharmacol. 2001 Sep;364(3):285-90 9614197 - Mol Pharmacol. 1998 Jun;53(6):969-73 10471087 - Neuropharmacology. 1999 Sep;38(9):1335-42 2555322 - J Biol Chem. 1989 Nov 25;264(33):19535-9 9723959 - Br J Pharmacol. 1998 Aug;124(7):1463-6 12672232 - J Med Chem. 2003 Apr 10;46(8):1318-29 10788429 - J Biol Chem. 2000 May 5;275(18):13243-9 12787824 - Eur J Pharmacol. 2003 May 30;470(1-2):1-7 8787135 - Trends Neurosci. 1996 Jan;19(1):13-8 11111826 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):310-23 8159738 - Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3275-9 12660218 - J Leukoc Biol. 2003 Apr;73(4):442-7 12694404 - J Neurochem. 2003 May;85(3):779-90 2895645 - Biochem Biophys Res Commun. 1988 Mar 30;151(3):1205-12 6214553 - J Biol Chem. 1982 Oct 10;257(19):11510-6 2592429 - J Cell Physiol. 1989 Dec;141(3):606-17 1348186 - Biochemistry. 1992 Mar 31;31(12):3193-7 3259582 - J Cell Physiol. 1988 May;135(2):269-76 8515840 - Neuroscience. 1993 May;54(1):15-36 15379893 - J Neurochem. 2004 Oct;91(1):119-32 1712731 - Exp Cell Res. 1991 Aug;195(2):368-75 14522842 - Br J Pharmacol. 2003 Oct;140(3):507-19 11267999 - J Cell Physiol. 2001 May;187(2):196-208 9530930 - Neurosci Lett. 1998 Feb 20;242(3):159-62 1850750 - J Cell Physiol. 1991 Mar;146(3):483-94 12482951 - Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17179-84 10869734 - J Auton Nerv Syst. 2000 Jul 3;81(1-3):289-94 12849743 - Neuroscience. 2003;120(1):85-98 1358898 - J Cell Physiol. 1992 Nov;153(2):221-33 14567069 - Vascul Pharmacol. 2002 Dec;39(6):309-15 9416670 - Trends Neurosci. 1997 Dec;20(12):570-7 11171941 - Pharmacol Rev. 2001 Mar;53(1):107-18 11831909 - J Med Chem. 2002 Feb 14;45(4):962-72 10551009 - Prog Brain Res. 1999;120:333-42 14523092 - J Neurosci. 2003 Oct 1;23 (26):8903-10 2813367 - Proc Natl Acad Sci U S A. 1989 Oct;86(20):7904-8 4053038 - Cancer Res. 1985 Nov;45(11 Pt 2):5663-9 12437584 - J Neurochem. 2002 Dec;83(5):1129-38 2708449 - J Cell Physiol. 1989 Apr;139(1):109-15 14623769 - Br J Pharmacol. 2003 Dec;140(8):1381-8 11256077 - Nat Rev Neurosci. 2001 Mar;2(3):165-74 12098642 - Neurosci Lett. 2002 Jul 19;327(2):87-90 15024037 - J Pharmacol Exp Ther. 2004 Jul;310(1):407-16 11111827 - Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):324-39 2175913 - Proc Natl Acad Sci U S A. 1990 Dec;87(24):9717-21 15953819 - Mol Neurobiol. 2005;31(1-3):169-83 12236792 - Bioconjug Chem. 2002 Sep-Oct;13(5):1100-11 9597157 - Annu Rev Pharmacol Toxicol. 1998;38:289-319 11099777 - Neurochem Int. 2001 Mar;38(3):199-207 2022702 - J Cell Physiol. 1991 Mar;146(3):473-82 11292387 - Cell Calcium. 2001 May;29(5):299-309 14522840 - Br J Pharmacol. 2003 Oct;140(3):441-3 8579591 - Biochem Biophys Res Commun. 1996 Jan 26;218(3):783-8 9599406 - Semin Cell Dev Biol. 1998 Apr;9(2):119-27 11871639 - Clin Med (Lond). 2002 Jan-Feb;2(1):45-53 10570953 - FEBS Lett. 1999 Sep 24;458(3):424-8 9755289 - Pharmacol Rev. 1998 Sep;50(3):413-92 198725 - Pain. 1977 Aug;3(4):367-77 9792648 - J Biol Chem. 1998 Nov 6;273(45):29437-44 2264825 - Biochem J. 1990 Nov 15;272(1):217-21 10727719 - Neuropharmacology. 2000 Apr 3;39(6):1083-94 12270951 - Physiol Rev. 2002 Oct;82(4):1013-67 10551008 - Prog Brain Res. 1999;120:323-32 9521483 - Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):111-20 12595918 - Cardiovasc Drug Rev. 2003 Spring;21(1):67-76 11056181 - Brain Res. 2000 Nov 3;882(1-2):26-35 10836147 - Annu Rev Pharmacol Toxicol. 2000;40:563-80 11959804 - Br J Pharmacol. 2002 Apr;135(8):2004-10 11331301 - J Cell Biol. 2001 Apr 30;153(3):491-501 11093790 - Mol Pharmacol. 2000 Dec;58(6):1502-10 14670955 - J Biol Chem. 2004 Feb 27;279(9):8212-8 10341225 - J Neurosci. 1999 Jun 1;19(11):4211-20 12588784 - Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):357-62 9113369 - Br J Pharmacol. 1997 Apr;120(8):1483-90 11707406 - EMBO J. 2001 Nov 15;20(22):6347-58 11171937 - Pharmacol Rev. 2001 Mar;53(1):1-24 15001573 - J Biol Chem. 2004 May 7;279(19):19790-9 7819532 - Neuroreport. 1994 Aug 15;5(13):1617-20 |
References_xml | |
SSID | ssj0022107 |
Score | 1.8695753 |
SecondaryResourceType | review_article |
Snippet | Trophic factors are required to ensure neuronal viability and regeneration after neural injury. Although abundant information is available on the factors that... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 65 |
SubjectTerms | Animals Benzenesulfonates - pharmacology Cells Humans Kinases Neurological disorders Neurons Neurons - cytology Neurons - drug effects Neurons - physiology Proteins Purinergic P2 Receptor Agonists Purinergic P2 Receptor Antagonists Receptors, Purinergic P2 - physiology Signal transduction Signal Transduction - drug effects Signal Transduction - physiology Studies |
Title | Mechanisms for inhibition of P2 receptors signaling in neural cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15953812 https://www.proquest.com/docview/214801652 https://search.proquest.com/docview/67933106 https://search.proquest.com/docview/860372540 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTxsxEB5BcumlKqWPFJr6UHGzsNfvXFCCiBBSVqgqUm6W92E1BzahGw7994w3m7QXeral9fox833j8TcA35mIMSiuqQ1SUFlaQYPLkoqotBWTwZVFeu-8yPXtg7xbqmWfm9P2aZV7m9gZ6mpdphj5ZcaT0IlW2dXmiaaiUelyta-gcQxDbGZsAMPZTX7_48C4kM_spD6doEZL24tsCqsuF_lE8AmnYsKSY_nXKb2CNDuPM38Hb3uoSKa7tT2Bo7p5D6fTBmny4x9yQbrkzS4qfgrXizo94V21jy1BGEpWza9V0WVjkXUk9xlBw1ZvUmUdkjI2QnqEjp1IkrPEb6TwffsBHuY3P69vaV8fgZbCqC3lTgaW4hGhQMdbOBljXcXS1sh6kFpJZbVmwaYoJxKNaJ0pTRSCB4HAqsCT9xEGzbqpPwNhxpTOxsijjNIFEVSwVlcIXmQlS8NGcLGfIL_ZyWD47i7MKr_IveCee-FxJkdwtp8-35-G1h_WbgTfDq24jdPPhaZeP7deo51ApKlHQF7pYTUTBuksjuXTbln-jkQ5tNs8-_Lfj5_Bm053tYufnMNg-_u5_oqIYluM4dgszRiG0_lslo_7XfQCItvKOw |
link.rule.ids | 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB5RONBL1RZaFtriQ8XNIo4fsfdSAQJtKYlQBRI3y3lY7IHs0iwH_n1nstktF3qOJTt-zHzfePwNwPdExhi0MNwGJbmqrOTBpaQiqmydqOCqkt4754WZ3KrLO3035OZ0Q1rlyib2hrqeVRQjP04FCZ0Ynf6YP3IqGkWXq0MFjTewRUpVyL22Ts-L699rxoV8Zin16STPjLKDyKa0-jgvxlKMBZfjhBzLS6f0CtLsPc7Fe3g3QEV2slzbD7DRtB9h56RFmvzwzI5Yn7zZR8V34Cxv6AnvtHvoGMJQNm3vp2WfjcVmkV2nDA1bM6fKOowyNgI9QsdGjOQssQ8K33e7cHtxfnM24UN9BF7JTC-4cCokFI8IJTre0qkYmzpWtkHWg9RKaWtMEixFOZFoROuyKotSiiARWJV48j7BZjtrmz1gSZZVzsYooorKBRl0sNbUCF5UraosGcHRaoL8fCmD4fu7MKt9XngpvPDS40yO4GA1fX44DZ1fr90IDtdfcRvTz4W2mT113qCdQKRpRsBeaWFNIjOksziWz8tl-TcS7dBui3T_v50fwvbkJr_yVz-LXwfwttdg7WMpX2Bz8eep-YroYlF-G_bQX8xfytI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LbxMxEB5BKiEuCCiPtEB9QL1ZsdfvXFApjcojqwhRqTfL-7DIoZvQTQ_8e8YbJ3Ap57Vkrx8z3zcefwPwnokYg-Ka2iAFlbUVNLgiqYhK2zAZXF2l987zUl9eyS_X6jpLCvU5rXJnEwdD3azqFCOfFDwJnWhVTGLOilh8mn1Y_6KpgFS6aM3VNB7CgZFasBEcfLwoF9_37Au5zVb20wlqtLRZcFNYNZmXU8GnnIopS07mXwd1D-ocvM_sKTzJsJGcbdf5GTxou-dweNYhZb75TU7JkMg5RMgP4Xzepue8y_6mJwhJybL7uayGzCyyimRREDRy7TpV2SEpeyOkB-nYiCRpS-wjhfL7F3A1u_hxfklzrQRaC6M2lDsZWIpNhAqdcOVkjG0Ta9siA0KaJZXVmgWbIp5IOqJ1pjZRCB4EgqwKT-FLGHWrrn0NhBlTOxsjjzJKF0RQwVrdIJCRjawNG8PpboL8eiuJ4Yd7Mav8vPSCe-6Fx5kcw_Fu-nw-Gb3fr-MYTvZfcUunnwtdu7rrvUabgahTj4Hc08JqJgxSWxzLq-2y_B2JcmjDeXH0385P4BFuH__tc_n1GB4PcqxDWOUNjDa3d-1bBBqb6l3eQn8AQzPPAA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mechanisms+for+inhibition+of+P2+receptors+signaling+in+neural+cells&rft.jtitle=Molecular+neurobiology&rft.au=Gonz%C3%A1lez%2C+Fernando+A&rft.au=Weisman%2C+Gary+A&rft.au=Erb%2C+Laurie&rft.au=Seye%2C+Cheikh+I&rft.date=2005-01-01&rft.pub=Springer+Nature+B.V&rft.issn=0893-7648&rft.eissn=1559-1182&rft.volume=31&rft.issue=1-3&rft.spage=65&rft_id=info:doi/10.1385%2FMN%3A31%3A1-3%3A065&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=1940183381 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-7648&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-7648&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-7648&client=summon |